Valion Bio
Biotechnology, Health Care
Valion Bio, Inc. is a Delaware corporation focused on advancing treatments for allergy, asthma, and other chronic diseases. The company aims to innovate in the MedTech industry. Valion Bio is dedicated to improving patient outcomes through targeted solutions.
Key facts
- Employees
- 51
- Industries
- Biotechnology, Health Care
- Status
- Public (VBIO)
- Website
- valionbio.com
- Company page
Recent activity at Valion Bio
Valion Bio funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Series B | $8.4M |
Leadership
- Michael, Chief Executive Officer
- Dean Zikria, Chief Executive Officer
Verified email and direct lines for Valion Bio’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Valion Bio in the news
- Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures - Yahoo Finance (Jun 11, 2026)
- With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge - Times Argus (Oct 14, 2026)
- Some patented drug imports face taxes up to 100%. Valion offers U.S. biologic production. - Stock Titan (Oct 14, 2026)
- Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone - FinancialContent (Oct 15, 2026)
- Press Release Distribution & Media Outreach Platform for PR Agencies - ACCESS Newswire (Oct 09, 2026)
- A new system showed a strong link to a cell-growth measure during fermentation. Valion Bio plans further development. - Stock Titan (Oct 15, 2026)
- VALION BIO BRIEFS PENTAGON LEADERSHIP ON ENTOLIMOD™ FOR ACUTE RADIATION SYNDROME - Yahoo Finance (Apr 28, 2026)
- A potential radiation drug could be absorbed through the mouth instead of injected. - Stock Titan (Oct 09, 2026)
Companies similar to Valion Bio
- Norris Medicines · Biotechnology, Health Care
- Medical Microinstruments · Biotechnology, Health Care
- Jasper Therapeutics · Biotechnology, Health Care
- COMPASS Pathways · Biotechnology, Health Care
- Apollomics · Biotechnology, Health Care
About Valion Bio: questions and answers
What does Valion Bio do?
Valion Bio, Inc. is a Delaware corporation focused on advancing treatments for allergy, asthma, and other chronic diseases. The company aims to innovate in the MedTech industry. Valion Bio is dedicated to improving patient outcomes through targeted solutions.
How many employees does Valion Bio have?
Valion Bio has about 51 employees.
Has Valion Bio raised funding?
Yes. Fundz has recorded 1 funding event for Valion Bio. The most recent, Series B of $8.4M, was in Oct 2026.
Who leads Valion Bio?
Michael is a Chief Executive Officer at Valion Bio.
What is the latest news on Valion Bio?
On Oct 07, 2026, Valion Bio Secures Funding of $8.4 Million
Is Valion Bio a public company?
Yes. Valion Bio is publicly traded under the ticker VBIO.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy